10X Genomics Inc (TXG)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2025 | 12-2024 | 09-2024 | 06-2024 | 03-2024 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -34,358 | -182,627 | -133,599 | -97,846 | -59,949 |
| Depreciation Amortization | 8,022 | 43,708 | 35,598 | 22,394 | 11,494 |
| Accounts receivable | 35,325 | 26,951 | 31,321 | 23,638 | 23,516 |
| Accounts payable and accrued liabilities | -2,547 | -3,354 | 10,044 | 5,705 | 4,583 |
| Other Working Capital | 28,280 | 2,338 | 2,630 | -10,362 | -6,297 |
| Other Operating Activity | -371 | 119,648 | 67,418 | 48,242 | 10,928 |
| Operating Cash Flow | $34,351 | $6,664 | $13,412 | $-8,229 | $-15,725 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | N/A | -19,238 | 29,638 | 29,367 | 13,542 |
| PPE Investments | -1,893 | -12,393 | -9,677 | -5,788 | -2,910 |
| Purchase Sale Intangibles | N/A | -1,000 | -1,000 | -1,000 | N/A |
| Other Investing Activity | 0 | -1,000 | -1,000 | -1,000 | 0 |
| Investing Cash Flow | $-1,893 | $-32,631 | $18,961 | $22,579 | $10,632 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 422 | 10,914 | 6,397 | 6,241 | 1,638 |
| Financing Cash Flow | $422 | $10,914 | $6,397 | $6,241 | $1,638 |
| Exchange Rate Effect | 114 | -164 | 105 | -51 | -48 |
| Beginning Cash Position | 344,067 | 359,284 | 359,284 | 359,284 | 359,284 |
| End Cash Position | 377,061 | 344,067 | 398,159 | 379,824 | 355,781 |
| Net Cash Flow | $32,994 | $-15,217 | $38,875 | $20,540 | $-3,503 |
| Free Cash Flow | |||||
| Operating Cash Flow | 34,351 | 6,664 | 13,412 | -8,229 | -15,725 |
| Capital Expenditure | -1,893 | -12,393 | -9,677 | -5,788 | -2,910 |
| Free Cash Flow | 32,458 | -5,729 | 3,735 | -14,017 | -18,635 |